Research reportMaternal dietary zinc supplementation prevents aberrant behaviour in an object recognition task in mice offspring exposed to LPS in early pregnancy
Introduction
Epidemiological studies have associated infections during pregnancy with the pathogenesis of cerebral palsy [1], [2], schizophrenia [3], [4], [5], [6], [7], non-genetic forms of autism [8], and mental retardation [9]. Studies in animals have confirmed that both bacterial and viral infections in utero can cause a spectrum of neuropathological and behavioural abnormalities in offspring [10], [11], [12], [13], [14], [15], [16], [17], [18], [19]. Although it remains unclear how a broad range of infectious agents might trigger neurodevelopment anomalies, accumulating evidence suggest that the damage may be due to the maternal immune response rather than the infectious agent itself [13], [14], [15], [16], [17], [18], [19]. Pro-inflammatory cytokines are the main mediators of the maternal response to infection [20]. Studies have focused upon the potential of maternal and fetal-derived cytokines (IL-6, IL-1-β and TNF-α) to inhibit brain development however their causative role still remains unclear [19], [21], [22]. Secondary products of the maternal immune response may also influence the developing brain. Early in infection, inflammatory cytokines mediate a complex change in acute-phase reactants in the host’s liver. Induction of the zinc (Zn)-binding protein, metallothionein (MT), is a component of this acute response which results in a well characterized maternal hypozincaemia [23], [24] and a subsequent fetal Zn deficiency [25], [26], [27], [28], [29]. Teratogenicity and abnormal neurodevelopment are associated with fetal Zn deficiency in rodents and humans [25], [26], [27], [28], [29], [30], [31], [33], [34], [35], [36] and this has been linked to MT-induction by a diverse range of toxicants including inflammatory mediators.
Daston and co-workers [25], [26], [27], [28] were the first to show that teratogenicity by a number of substances including urethane, α-hedrin, ethanol and TNF-α was related to induction of hepatic MT and linked to changes in maternal-fetal Zn distribution. Our group has since demonstrated in a mouse model that induction of MT in the mother’s liver results in a redistribution of whole body zinc that causes short-term fetal Zn deficiency [29], [30], [31], [32]. In infection, inflammatory mediators stimulate MT synthesis in the mother’s liver, which in turn sequesters Zn from the maternal blood thus competing with that available to the fetus. No specific storage sites of Zn exist in the body, therefore serum Zn concentrations must be maintained to ensure an adequate supply to the fetus for normal fetal development. It is well recognized that a dietary deficiency of Zn is teratogenic [33], [34] and causes neurological abnormalities with alterations in both brain structure and function in humans [34], [35], [36]. The mechanism of damage is unknown but likely to be complex as Zn is required for many proteins that are critically important in the processes that underlie development of the fetus including neurodevelopment (e.g. DNA and protein synthesis, mitosis and cell division) [23], [24].
In our studies we have used lipopolysaccharide (LPS), the bacterial cell wall on gram-negative bacteria, to evoke a maternal immune response during pregnancy. We have shown that early in pregnancy on gestational day (GD) 8 in the mouse, LPS-mediated induction of MT caused a sharp fall in plasma zinc which resulted in 8-times as many birth abnormalities per litter than in controls [30]. We have further demonstrated that LPS-mediated teratology is not observed in MT-knockout mice and that plasma zinc levels do not fall after prenatal LPS-treatment, implicating MT and Zn deficiency in the teratogenic process. In addition, we have found that LPS-induced birth abnormalities in wild type mice can be prevented by injecting Zn subcutaneously at the time of LPS treatment [30] or by supplementing the mother’s diet with Zn throughout pregnancy [32]. Although the mechanism by which Zn supplementation protects against birth abnormalities is unknown, we have shown that it can limit the fall in plasma Zn in the mother during the period of MT induction, where it can fall by as much as 40% after LPS exposure on GD 8 [30]. The question now arises as to whether Zn deficiency plays a causative role in abnormal neurodevelopment due to prenatal infection and whether dietary Zn supplementation throughout pregnancy is protective.
Behavioural anomalies [10], [11], [12], [13], [14], [15], [16], [17], [18] and molecular and cellular changes [18], [37] in brain regions typically involved in cognition have been observed in rodent offspring born to mother’s exposed to a variety infectious agents. Studies using either the viral mimic, PolyI:C or bacterial endotoxin have confirmed the importance of the maternal cytokine-associated inflammatory response in neurodevelopmental damage and behavioural pathology in later life [for review see 38]. The timing of maternal immune challenge in pregnancy has been found to alter the cytokine response and the pathological consequences in brain and behaviour [12]. From studies mainly using PolyI:C, the most vulnerable period where infection has the greatest impact on the developing brain appears to be in early rather than late pregnancy [12], [38]. Little is known about the effect of LPS challenge in early pregnancy and whether it causes a similar pathological profile to PolyI:C, as each are recognized by specific toll-like receptors [39], [40] and consequently are likely to produce different cytokine responses and neurodevelopmental outcomes.
Ethanol like many inflammatory mediators is a potent inducer of liver MT with a consequent reduction in plasma Zn [27], [28]. We and others have shown that prenatal ethanol exposure on GD 8 causes impairments in spatial memory and object recognition memory in offspring well before the major structures involved in memory processing are formed [41], [42], [43], [44]. Similar spatial memory impairments have been found in adult offspring prenatally exposed to PolyI:C on GD 9 [reviewed by 38]. Most interestingly our studies have shown that dietary zinc supplementation throughout pregnancy can prevent the ethanol-mediated cognitive impairments [42]. Given that LPS-administration in early pregnancy causes a higher MT response and a greater fall in plasma Zn than with ethanol [30], [45], we hypothesize that this will also result in neurodevelopmental damage. Such damage could be reflected by differential expression of major genes involved in processes such as neurodevelopment, inflammatory mediators or defense mechanisms. The aim of the present study is to determine whether LPS administration early in pregnancy affects cognition in offspring or changes in gene expression in the fetal brain. We also determine whether dietary zinc supplementation can prevent any LPS-related changes.
Section snippets
Animals
C57BL/6J mice were purchased from the Institute of Medical Veterinary Science (IMVS, Adelaide) and maintained in the animal care facility (22 °C, 12 h light-dark cycle). Access to water and a commercial non-purified diet (Milling Industries, Australia) were provided ad libitum unless otherwise stated in the study. Nulliparous females (6–8 weeks) were paired with males for overnight mating and on the following morning, females were examined for the presence of a vaginal plug. Confirmation of a
Physical data on mothers and offspring exposed to LPS
Maternal weight, number of litters and litter sizes are summarized in Table 2. There were no differences in maternal weights between treatments on GD 14, PD 3 or PD 21. There was a day effect [F(2,184) = 24.55, p < 0.001] where the maternal weight on PD 3 was lower than those on GD 12 or PD 21. There was a treatment effect on litter size at birth [F(1,76) = 20.74, p = 0.000] and a significant diet × treatment interaction [F(1,76) = 4.26, p = 0.042], where the litter size of the LPS group was smaller compared
Discussion
Prenatal LPS administration resulted in reduced litter size at birth and a reduction in the number of live fetuses in utero at GD 18, which was not apparent at GD 12. Although the decreased litter size with LPS did not coincide with a higher number of resorptions, we have found this in a previous study where there was a increased number of resorptions and decreased number of fetuses on GD 18 after LPS administration on GD 8 [30]. In that study we also found that subcutaneous zinc treatment at
Acknowledgements
The authors of this study would like to acknowledge Lisa Miller (Discipline of Public Health, The University of Adelaide) who performed the statistics for the water maze and object recognition task studies.
References (66)
- et al.
Neurotropic viruses and cerebral palsy: population based case-control study
BMJ
(2006) - et al.
Chorioamnionitis and cerebral palsy in term and near-term infants
JAMA
(2003) - et al.
Schizophrenic birth seasonality in relation to the incidence if infectious diseases and temperature extremes
Arch Gen Psychiatry
(1984) - et al.
Serologic evidence of prenatal influenza in the etiology of schizophrenia
Arch Gen Psychiatry
(2004) - et al.
Prenatal exposure to influenza as a risk factor for adult schizophrenia
Acta Psychiatr Scand
(2003) - et al.
Predictors of schizophrenia—a review
Br Med Bull
(2005) - et al.
Fetal environment and schizophrenia
Environ Health Perspect
(2005) - et al.
The neurobiology of infantile autism
Annu Rev Neurosci
(1995) - et al.
Urinary tract infections during pregnancy and mental retardation and developmental delay
Obstet Gynecol
(2000) - et al.
Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring
J Neurosci
(2003)
Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring
J Psychiatr Res
Prenatal and postnatal maternal contributions in the infection model of schizophrenia
Exp Brain Res
Immunological stress at the maternal-foetal interface: a link between neurodevelopment and adult psychopathology
Brain Behav Immun
Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia
Biol Psychiatry
Effects of maternal Campylobacter rectus infection on murine placenta, fetal and neonatal survival and brain development
J Periondontol
Prenatal immune challenge disrupts sensorimotor gating in adult rats: implications for the etiopathogenesis of schizophrenia
Neuropsychopharmacology
Maternal exposure to bacterial endotoxin during pregnancy enhances amphetamine-induced locomotion and startle responses in adult rat offspring
J Psychiatr Res
Specific neurodevelopmental damage in mice offspring following maternal inflammation during pregnancy
Neuropharmacology
The role of cytokines in mediating effects of prenatal infection on the fetus: implications for schizophrenia
Mol Psychiatry
Cytokines and fever
Int Arch Allergy Immunol
Maternal immune activation alters fetal brain development through interleukin-6
J Neurosci
Maternal LPS induces cytokines in the amniotic fluid and corticotropin releasing hormone in the fetal rat brain
Am J Physiol Regul Integr Comp Physiol
Absorption transport and hepatic metabolism of copper and zinc: special reference to metallothionein and caeruloplasmin
Physiol Rev
The biochemical basis of zinc physiology
Nutr Rev
The role of metallothionein induction and altered zinc status in maternally mediated developmental toxicity: comparison of the effects of urethane and styrene
Toxicol Appl Pharmacol
Keen CL Altered zinc status by α-hedrin in the pregnant rat and its relationship to adverse developmental outcome
Reprod Toxicol
Altered maternal zinc metabolism following exposure to diverse developmental toxicants
Reprod Toxicol
Tumour necrosis factor-α alters maternal and embryonic zinc metabolism and is developmentally toxic in mice
J Nutr
Ethanol decrease zinc transfer to the fetus in normal but not metallothionein-null mice
Alcohol Clin Exp Res
Zinc treatment prevents lipopolysaccharide-induced teratogenicity in mice
Birth Defects Res
Metallothione: the multipurpose protein
Cell Mol Life Sci
Dietary zinc supplementation ameliorates LPS-induced teratogenicity in mice
Pediatr Res
The teratogenic effect of zinc deficiency and accompanying feeding patterns in mice
Proc Soc Exp Biol Med
Cited by (91)
Maternal immune activation in rodent models: A systematic review of neurodevelopmental changes in gene expression and epigenetic modulation in the offspring brain
2021, Neuroscience and Biobehavioral ReviewsZinc, but not paracetamol, prevents depressive-like behavior and sickness behavior, and inhibits interferon-gamma and astrogliosis in rats
2020, Brain, Behavior, and ImmunityPrenatal zinc supplementation attenuates lipopolysaccharide-induced behavioral impairments in maternal immune activation model
2020, Behavioural Brain ResearchCitation Excerpt :Interestingly, an animal study has shown that gestational exposure to LPS leads to a sharp reduction in maternal zinc plasma level which induces abnormalities in fetuses [25,26]. Another study by the same group demonstrated that zinc supplementation throughout pregnancy can prevent the memory impairment induced by prenatal LPS exposure (0.3 mg/kg, s.c., GD8) [50]. Likewise, our results revealed that zinc supplementation given from the first day of pregnancy attenuated spatial working memory impairment as well as recognition memory deficit in the male pups prenatally treated with LPS.
Inflammation-dependent ISG15 upregulation mediates MIA-induced dendrite damages and depression by disrupting NEDD4/Rap2A signaling
2019, Biochimica et Biophysica Acta - Molecular Basis of Disease